lifesciences

Latest stories

  • in Health care

    Zydus Lifesciences bags USFDA nod for pulmonary drug Roflumilast

    by

    Ahmedabad: Pharma major, Zydus Lifesciences Limited, has announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Roflumilast Tablets, 250 mcg (USRLD: Daliresp Tablets, 250 mcg). Roflumilast reduces inflammation in the lungs which leads to chronic obstructive pulmonary disease (COPD). It is used to […] More

  • in Health care

    USFDA nod to Zydus Lifesciences Estradiol Transdermal System for postmenopausal osteoporosis prevention

    USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections

    by

    Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Estradiol Transdermal System USP, 0.014 mg/day (weekly) (USRLD: Menostar Transdermal System). Estradiol transdermal system is indicated for prevention of postmenopausal osteoporosis. The drug will be manufactured at the group’s formulation manufacturing facility in Moraiya, […] More

  • in Health care

    Zydus Lifesciences bags USFDA okay for Isoproterenol Hydrochloride Injection

    Zydus Lifesciences bags USFDA okay for Isoproterenol Hydrochloride Injection

    by

    Ahmedabad: Drugmaker, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isoproterenol Hydrochloride Injection USP, 0.2 mg/mL and 1 mg/5 mL (0.2 mg/mL) single-dose vials (USRLD: Isuprel Injection). Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock […] More

  • in Health care

    Revise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine with Yellow Fever Vaccine

    Revise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine with Yellow Fever Vaccine

    by

    New Delhi: In response to the drug major Zydus Life Sciences’ proposal to conduct Phase IV clinical for Typhoid Vi Conjugate Vaccine I.P.(TCV) with Yellow Fever Vaccine(YFV), the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the firm to revise the Phase IV clinical trial protocol. This came after […] More

  • in Health care

    Glenmark Pharma weighs selling stake in Glenmark Lifesciences

    Glenmark Pharma weighs selling stake in Glenmark Lifesciences

    by

    Bengaluru: India’s Glenmark Pharmaceuticals Ltd is considering selling a majority of the 82% stake it holds in Glenmark Life Sciences Ltd as it looks to lower its debt load, the Mint business daily reported on Tuesday. Glenmark Pharma has hired Kotak Mahindra Capital Co Ltd to oversee the sale of its stake in Glenmark Life and […] More

  • in Health care

    USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections

    USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections

    by

    Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Tavaborole Topical Solution, 5% (USRLD: Kerydin Topical Solution). Tavaborole topical solution is indicated to treat fungal toenail infections. These are the infections that may cause nail discoloration, splitting, or pain. The drug will be […] More

  • in Health care

    Zydus Lifesciences bags USFDA nod for Azithromycin Tablets to treat certain bacterial infections

    Zydus Lifesciences bags USFDA nod for Azithromycin Tablets to treat certain bacterial infections

    by

    Ahmedabad: Drugmaker, Zydus Lifesciences Limited, has announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Azithromycin Tablets USP, 500 mg (USRLD: Zithromax Tablets). Azithromycin is indicated to treat certain bacterial infections such as bronchitis, pneumonia, sexually transmitted diseases (STD), infections of the ears, […] More

  • in Health care

    Zydus Lifesciences bags USFDA approval for Carbidopa and Levodopa Tablets to treat Parkinson’s disease symptoms

    by

    Ahmedabad: Zydus Lifesciences Limited today  announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg (USRLD: Sinemet Tablets, 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg). Carbidopa […] More

  • in Health care

    USFDA nod to Zydus Lifesciences glaucoma drug Acetazolamide

    by

    Ahmedabad: Pharma major, Zydus Lifesciences Limited, has announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Acetazolamide Tablets USP, 125 mg and 250 mg (USRLD: Diamox Tablets, 125 mg and 250 mg). Acetazolamide is used to treat glaucoma, a condition in which increased pressure […] More

  • in Health care

    Zydus Lifesciences Depression drug Doxepin Hydrochloride bags USFDA okay

    by

    Ahmedabad: Pharma major, Zydus Lifesciences Limited, has announced that the company has received final approval for Doxepin Hydrochloride Capsules USP, 150 mg (USRLD: Sinequan Capsules) from the United States Food and Drug Administration (USFDA). Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety. It helps improve moods and feelings of […] More